Silvercrest Asset Management Group »

Apellis Pharmaceuticals shares owned by Silvercrest Asset Management Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Silvercrest Asset Management Group from 13F filings

Historical chart of Silvercrest Asset Management Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Silvercrest Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Silvercrest Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.3M 191k 22.63

More positions owned by Silvercrest Asset Management Group

Microsoft Corporation (MSFT)
Broadcom (AVGO)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Rus 1000 Grw Etf (IWF)
Abbott Laboratories (ABT)
Oracle Corporation (ORCL)
Cadence Bank (CADE)
Glacier Ban (GBCI)
Home Depot (HD)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Williams Companies (WMB)
Cisco Systems (CSCO)
Atmos Energy Corporation (ATO)
Alphabet Inc Class A cs (GOOGL)

View all positions for Silvercrest Asset Management Group

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Morgan Stanley
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors

View all funds holding Apellis Pharmaceuticals